Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicenter, randomized, double-blind, prospective study comparing the safety and efficacy of ABT-335 and rosuvastatin calcium combination therapy to ABT-335 and rosuvastatin calcium monotherapy in subjects with mixed dyslipidemia

Next Previous
X
Search
Trial Profile

A multicenter, randomized, double-blind, prospective study comparing the safety and efficacy of ABT-335 and rosuvastatin calcium combination therapy to ABT-335 and rosuvastatin calcium monotherapy in subjects with mixed dyslipidemia

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 25 Sep 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Choline fenofibrate (Primary) ; Rosuvastatin (Primary)
  • Indications Dyslipidaemias; Lipid metabolism disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors Abbott Laboratories

    • Most Recent Events

    • 08 Jun 2009 Results of a retrospective analysis were presented at the 69th annual meeting of the American Diabetes Association, according to a Abbott Laboratories media release.
    • 03 Jun 2008 Primary endpoints all met. Results presented at the American Society of Clinical Oncology (ASCO) 2008.
    • 02 Jun 2008 Results data have been reported at the National Lipid Association 2008 meeting and in a media release from Abbott.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top